Authors

• Fangfang Fan (ORCID: https://orcid.org/0000-0001-8351-4821)
• Changsheng Ma (ORCID: https://orcid.org/0000-0002-5387-5957)
• Xia Yulong (ORCID: https://orcid.org/0000-0002-2998-2074)
• Jing Liu (ORCID: https://orcid.org/0000-0002-3311-0818)
• Dong Zhao (ORCID: https://orcid.org/0000-0002-3239-3449)
• Yannan Pan (ORCID: https://orcid.org/0000-0003-4868-6649)
• Yongchen Hao (ORCID: https://orcid.org/0000-0002-6519-6185)
• Yong Huo (ORCID: https://orcid.org/0000-0002-5407-8773)
• Yan Zhang (ORCID: https://orcid.org/0000-0002-7508-4160)
• Jianping Li (ORCID: https://orcid.org/0000-0002-8526-1095)
• Jie Jiang (ORCID: https://orcid.org/0000-0002-4077-0056)
• Jing Zhou (ORCID: https://orcid.org/0000-0002-8896-0019)
• Na Yang (ORCID: https://orcid.org/0000-0001-9022-171X)
• Jun Liu (ORCID: https://orcid.org/0009-0007-0470-221X)

Institutions

• Capital Medical University (CN)
• Peking University (CN)
• Beijing Anzhen Hospital (CN)
• Peking University First Hospital (CN)

Publication Details

Journal

Journal of the American Heart Association

Published

2024-09-30

DOI

https://doi.org/10.1161/jaha.123.033941

Citations

2

Primary Topic

Atrial Fibrillation Management and Outcomes

Type

article

Field-Weighted Citation Impact

0.80

Funders

• American Heart Association
• Pfizer
• AstraZeneca